Cargando…

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood

INTRODUCTION: Maternally derived antibodies are crucial for neonatal immunity. Understanding the binding and cross-neutralization capacity of maternal and cord antibody responses to SARS-CoV-2 variants following COVID-19 vaccination in pregnancy can inform neonatal immunity. METHODS: Here we charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Govindaraj, Sakthivel, Cheedarla, Narayanaiah, Cheedarla, Suneethamma, Irby, LesShon S., Neish, Andrew S., Roback, John D., Smith, Alicia K., Velu, Vijayakumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350671/ https://www.ncbi.nlm.nih.gov/pubmed/37465682 http://dx.doi.org/10.3389/fimmu.2023.1211558

Ejemplares similares

Impact of COVID-19 Vaccination on Pregnant Women
por: Chaubey, Ishaan, et al.
Publicado: (2023)

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023)

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2023)

Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
por: Faliti, Caterina E., et al.
Publicado: (2023)

PATIENTS WITH ASTHMA OR ATOPIC DERMATITIS TAKING BIOLOGIC THERAPIES HAVE REDUCED SARS-COV-2 VACCINE RESPONSE AT SIX MONTHS
por: RUNNSTROM, MARTIN C, et al.
Publicado: (2022)

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
por: Patel, Anamika, et al.
Publicado: (2022)

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
por: Patel, Anamika, et al.
Publicado: (2023)

Establishment of a COVID-19 perinatal biorepository in a safety net population
por: Forrest, Alexandra D., et al.
Publicado: (2022)

Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
por: Cheedarla, Narayanaiah, et al.
Publicado: (2018)

371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January–March 2021
por: Graciaa, Daniel, et al.
Publicado: (2021)

Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
por: Cheedarla, Narayanaiah, et al.
Publicado: (2017)

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2022)

SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
por: Chaubey, Ishaan, et al.
Publicado: (2021)

Editorial: CD4+ T cells in HIV: A Friend or a Foe?
por: Govindaraj, Sakthivel, et al.
Publicado: (2023)

Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
por: Sullivan, David J, et al.
Publicado: (2022)

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
por: Nooka, Ajay K., et al.
Publicado: (2022)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
por: Zapata-Cardona, María I., et al.
Publicado: (2022)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2022)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2023)

Evaluating the impact of three progestin-based hormonal contraceptive methods on immunologic changes in the female genital tract and systemically (CHIME Study): a prospective cohort study protocol
por: Haddad, Lisa B., et al.
Publicado: (2022)

Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
por: Sahoo, Anusmita, et al.
Publicado: (2022)

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
por: Verkerke, Hans P, et al.
Publicado: (2022)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Antibody Titer Correlates with Omicron Infection in Vaccinated Healthcare Workers
por: Mollura, Maximiliano, et al.
Publicado: (2022)

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
por: Sullivan, David J., et al.
Publicado: (2022)

Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients
por: Gaete-Argel, Aracelly, et al.
Publicado: (2023)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers
por: Cai, Bing, et al.
Publicado: (2019)

Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
por: Babu, Hemalatha, et al.
Publicado: (2019)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
por: Kitchin, Dale, et al.
Publicado: (2022)

Evidence for Congenital Zika Virus Infection From Neutralizing Antibody Titers in Maternal Sera, Northeastern Brazil
por: Moreira-Soto, Andres, et al.
Publicado: (2017)

Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
por: SOMA, Takehisa, et al.
Publicado: (2018)

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
por: Gilbert, Peter B., et al.
Publicado: (2022)

302. Investigating NAI Titer as a Neutralizing IAV Correlate of Protection
por: Rumfelt, Kalee E, et al.
Publicado: (2023)

Maternal psychological stress-induced developmental disability, neonatal mortality and stillbirth in the offspring of Wistar albino rats
por: Govindaraj, Sakthivel, et al.
Publicado: (2017)

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01039gar8pd9plkqhft0gfd3jn